An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

There are plenty of radios you can buy that pick up MW and SW bands if that’s what you’re into. Or, you can follow [mircemk]’s example, and whip one up yourself instead. The build employs an ESP32 as ...

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Joshua Lyon Joshua Lyon is a writer covering home and decor. He requires nine ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

See Statistics Help for definitions of terms used.